Agenus Inc is a biotechnology company focused on discovering and developing immuno-oncology therapies that harness the body’s immune system to fight cancer

The company is engaged in research and innovative solutions for a range of cancer treatments, including checkpoint inhibitors and other immunotherapeutics. With an emphasis on enhancing patient outcomes, Agenus collaborates with various partners to advance its pipeline of therapeutic candidates and facilitate the development of novel approaches to cancer treatment. The company's commitment to expanding immuno-oncology options aims to improve the overall effectiveness of cancer therapies and patient quality of life.